Abstract 5664: A bispecific IgM antibody format for enhanced T cell dependent killing with minimal cytokine releaseRamesh Baliga, Bruce A. Keyt, Dean Ng et al.|Cancer Research|2020Cited by 3
Abstract 4179: High valency of IGM-2323, a CD20xCD3 IgM bispecific T cell engager, displaces rituximab binding and induces potent B lymphoma cell killingKevin C. Hart, Maya F. Kotturi, Kathryn Logronio et al.|Cancer Research|2022Cited by 1